Matches in Wikidata for { <http://www.wikidata.org/entity/Q34585047> ?p ?o ?g. }
- Q34585047 description "2014 nî lūn-bûn" @default.
- Q34585047 description "2014 թուականի Յունիսին հրատարակուած գիտական յօդուած" @default.
- Q34585047 description "2014 թվականի հունիսին հրատարակված գիտական հոդված" @default.
- Q34585047 description "2014年の論文" @default.
- Q34585047 description "2014年論文" @default.
- Q34585047 description "2014年論文" @default.
- Q34585047 description "2014年論文" @default.
- Q34585047 description "2014年論文" @default.
- Q34585047 description "2014年論文" @default.
- Q34585047 description "2014年论文" @default.
- Q34585047 description "2014年论文" @default.
- Q34585047 description "2014年论文" @default.
- Q34585047 description "2014年论文" @default.
- Q34585047 description "2014年论文" @default.
- Q34585047 description "2014年论文" @default.
- Q34585047 description "2014년 논문" @default.
- Q34585047 description "article científic" @default.
- Q34585047 description "article scientific" @default.
- Q34585047 description "article scientifique (publié 2014)" @default.
- Q34585047 description "articol științific" @default.
- Q34585047 description "articolo scientifico" @default.
- Q34585047 description "artigo científico (publicado na 2014)" @default.
- Q34585047 description "artigo científico (publicado na 2014)" @default.
- Q34585047 description "artigo científico" @default.
- Q34585047 description "artikull shkencor" @default.
- Q34585047 description "artikulong pang-agham" @default.
- Q34585047 description "artykuł naukowy" @default.
- Q34585047 description "artículo científico publicado en 2014" @default.
- Q34585047 description "artículu científicu espublizáu en 2014" @default.
- Q34585047 description "bilimsel makale" @default.
- Q34585047 description "bài báo khoa học" @default.
- Q34585047 description "mokslinis straipsnis" @default.
- Q34585047 description "naučni članak" @default.
- Q34585047 description "scienca artikolo" @default.
- Q34585047 description "scientific article" @default.
- Q34585047 description "teaduslik artikkel" @default.
- Q34585047 description "tieteellinen artikkeli" @default.
- Q34585047 description "tudományos cikk" @default.
- Q34585047 description "vedecký článok" @default.
- Q34585047 description "vetenskaplig artikel" @default.
- Q34585047 description "videnskabelig artikel (udgivet 2014)" @default.
- Q34585047 description "vitenskapelig artikkel" @default.
- Q34585047 description "vitskapeleg artikkel" @default.
- Q34585047 description "vědecký článek" @default.
- Q34585047 description "wetenschappelijk artikel" @default.
- Q34585047 description "wissenschaftlicher Artikel" @default.
- Q34585047 description "επιστημονικό άρθρο" @default.
- Q34585047 description "мақолаи илмӣ" @default.
- Q34585047 description "мақолаи илмӣ" @default.
- Q34585047 description "наукова стаття, опублікована в червні 2014" @default.
- Q34585047 description "научна статия" @default.
- Q34585047 description "научная статья" @default.
- Q34585047 description "научни чланак" @default.
- Q34585047 description "научни чланак" @default.
- Q34585047 description "מאמר מדעי" @default.
- Q34585047 description "سائنسی مضمون" @default.
- Q34585047 description "مقالة علمية" @default.
- Q34585047 description "مقالهٔ علمی" @default.
- Q34585047 description "২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q34585047 description "บทความทางวิทยาศาสตร์" @default.
- Q34585047 description "სამეცნიერო სტატია" @default.
- Q34585047 name "A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group" @default.
- Q34585047 name "A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group" @default.
- Q34585047 name "A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group" @default.
- Q34585047 type Item @default.
- Q34585047 label "A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group" @default.
- Q34585047 label "A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group" @default.
- Q34585047 label "A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group" @default.
- Q34585047 prefLabel "A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group" @default.
- Q34585047 prefLabel "A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group" @default.
- Q34585047 prefLabel "A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group" @default.
- Q34585047 P1433 Q34585047-A7DFBB6F-6C5E-4857-A810-37C67A9011C7 @default.
- Q34585047 P1476 Q34585047-16FAA1D7-15FB-4C3B-8706-A59FABA7FDFB @default.
- Q34585047 P2093 Q34585047-12B7918E-E443-42F4-8928-519893E8ABD1 @default.
- Q34585047 P2093 Q34585047-3105A7A8-2400-4195-836A-AA01D6338729 @default.
- Q34585047 P2093 Q34585047-3662014F-186C-49DD-A248-2BA7BC3D00DB @default.
- Q34585047 P2093 Q34585047-3DCC1A3D-1C6D-4E96-9B7C-F71A0A9B4CDB @default.
- Q34585047 P2093 Q34585047-6EF3A08F-D2D3-4A76-8EC6-68C45C2D4EA3 @default.
- Q34585047 P2093 Q34585047-75F116B5-D933-47D4-89AB-7AED4836DBE4 @default.
- Q34585047 P2093 Q34585047-77AC6897-7DA0-44D3-AC6E-05494D1F2FB2 @default.
- Q34585047 P2093 Q34585047-78C89873-95F3-49FD-B373-92C47677C689 @default.
- Q34585047 P2093 Q34585047-80E89CD7-95CA-49DA-864F-E6FCF1059028 @default.
- Q34585047 P2093 Q34585047-9D06C039-E417-4735-914B-4E07914D29C1 @default.
- Q34585047 P2093 Q34585047-A5A05F3A-A9BC-41EC-84F1-ED2734E756E5 @default.
- Q34585047 P2093 Q34585047-CDE0F4E3-C020-4BAF-A61F-B6A5549DE97E @default.
- Q34585047 P2093 Q34585047-FA1CD9D7-F597-4D11-9772-BBBB5C534304 @default.
- Q34585047 P2860 Q34585047-04968371-1152-40B4-8172-13E247DF33B4 @default.
- Q34585047 P2860 Q34585047-0A54C6F5-939E-4121-AB00-FA2701E4C25D @default.
- Q34585047 P2860 Q34585047-0DD01F75-D76B-4659-971A-4B68094B1510 @default.
- Q34585047 P2860 Q34585047-14CB83CF-29E1-4ED3-BF3B-37E0C77CCF55 @default.
- Q34585047 P2860 Q34585047-155FBA7B-7C20-459D-B50F-F3B3842A1A67 @default.
- Q34585047 P2860 Q34585047-163428EC-5688-42B7-980E-E9ABF8D6557F @default.
- Q34585047 P2860 Q34585047-1CDD8273-0252-4835-961D-DC39C2D1D366 @default.
- Q34585047 P2860 Q34585047-21235131-F231-44D0-9F31-EEBB5A8499AF @default.
- Q34585047 P2860 Q34585047-236C4069-7A61-4CE8-8765-C577BF9545D6 @default.
- Q34585047 P2860 Q34585047-268CC8B6-587C-4547-9357-7275EEE45191 @default.
- Q34585047 P2860 Q34585047-27A7FA7D-4439-409F-ACAE-3BC094B0C70F @default.
- Q34585047 P2860 Q34585047-29D3F74B-3B54-4115-9AF0-4AF0873D9421 @default.
- Q34585047 P2860 Q34585047-371B66B3-6116-4DF0-A2BA-85E9FD654ACA @default.
- Q34585047 P2860 Q34585047-37FD0B00-5D40-461D-9C4D-24131662B18A @default.